Capricor Therapeutics Inc (CAPR)

[Rogerthat1]

$CAPR getting dmd bla clearance is highest priority for the co imo. Make no mistake. They’re going the exosomes rebranding route but the covid therapeutic trial is just another piece in the bla approval puzzle imo. They are after patient safety data from those patients whose breathing and heart conditions are compromised. Not too different from fragile dmd population. So is the OLE trial that they immediately launched after Hope 2. They both serve a purpose. That is bla for dmd.

Secondary purpose of ole for all patients could be to appease the dmd and ppmd crowd and keep having them fight for Capricor.

If you take some time to think what Linda is doing, you’ll see the pieces coming together. Bashing the co for 30-40¢ price drop is easy but there is no money involved in it imo.